Striae distensae: Preventative and therapeutic modalities to improve aesthetic appearance

Nicholas A. Ross, Derek Ho, Juliya Fisher, Andrew Mamalis, Edward Heilman, Nazanin Saedi, Jared Jagdeo

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

BACKGROUND Striae distensae (SD) are aesthetically troublesome to patients and therapeutically challenging. OBJECTIVE Herein, the authors comprehensively review the literature pertaining to the history, pathogenesis, clinical presentation, clinical rating scales, and laboratory, imaging, and histologic features of SD. METHODS AND MATERIALS A review of PubMed, MEDLINE, Scopus, Embase, and Google scholar was conducted, including literature published from 1773 to August 6, 2016. RESULTS The authors identified 68 articles that met inclusion and exclusion criteria. CONCLUSION There are few randomized controlled trials evaluating the long-term efficacy and safety of various topical and energy-based devices. Based on clinical and anecdotal experience, both nonablative and ablative fractionated lasers have shown modest SD improvement compared with other treatment modalities (including Excimer laser, CuBr laser, pulsed dye laser, and 1,064-nm Nd:YAG laser). In the authors' experience, 1,540-nm nonablative fractionated laser is a worthy first-line modality for the treatment of SD. Future researchers may consider greater focus on enhanced study design, including larger, long-term split-body, or split-SD head-to-head randomized comparative trials with objective outcome measures and end points, such as biopsy and molecular studies demonstrating increased collagen and elastic fibers that correlate to clinical improvement.

Original languageEnglish (US)
Pages (from-to)635-648
Number of pages14
JournalDermatologic Surgery
Volume43
Issue number5
DOIs
StatePublished - 2017

Fingerprint

Striae Distensae
Esthetics
Lasers
Dye Lasers
Therapeutics
Excimer Lasers
Elastic Tissue
Solid-State Lasers
PubMed
MEDLINE
Collagen
Randomized Controlled Trials
History
Research Personnel
Outcome Assessment (Health Care)
Biopsy
Safety
Equipment and Supplies

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Striae distensae : Preventative and therapeutic modalities to improve aesthetic appearance. / Ross, Nicholas A.; Ho, Derek; Fisher, Juliya; Mamalis, Andrew; Heilman, Edward; Saedi, Nazanin; Jagdeo, Jared.

In: Dermatologic Surgery, Vol. 43, No. 5, 2017, p. 635-648.

Research output: Contribution to journalReview article

Ross, Nicholas A. ; Ho, Derek ; Fisher, Juliya ; Mamalis, Andrew ; Heilman, Edward ; Saedi, Nazanin ; Jagdeo, Jared. / Striae distensae : Preventative and therapeutic modalities to improve aesthetic appearance. In: Dermatologic Surgery. 2017 ; Vol. 43, No. 5. pp. 635-648.
@article{a6e6463cbd7f4f19a602474dc225d7e1,
title = "Striae distensae: Preventative and therapeutic modalities to improve aesthetic appearance",
abstract = "BACKGROUND Striae distensae (SD) are aesthetically troublesome to patients and therapeutically challenging. OBJECTIVE Herein, the authors comprehensively review the literature pertaining to the history, pathogenesis, clinical presentation, clinical rating scales, and laboratory, imaging, and histologic features of SD. METHODS AND MATERIALS A review of PubMed, MEDLINE, Scopus, Embase, and Google scholar was conducted, including literature published from 1773 to August 6, 2016. RESULTS The authors identified 68 articles that met inclusion and exclusion criteria. CONCLUSION There are few randomized controlled trials evaluating the long-term efficacy and safety of various topical and energy-based devices. Based on clinical and anecdotal experience, both nonablative and ablative fractionated lasers have shown modest SD improvement compared with other treatment modalities (including Excimer laser, CuBr laser, pulsed dye laser, and 1,064-nm Nd:YAG laser). In the authors' experience, 1,540-nm nonablative fractionated laser is a worthy first-line modality for the treatment of SD. Future researchers may consider greater focus on enhanced study design, including larger, long-term split-body, or split-SD head-to-head randomized comparative trials with objective outcome measures and end points, such as biopsy and molecular studies demonstrating increased collagen and elastic fibers that correlate to clinical improvement.",
author = "Ross, {Nicholas A.} and Derek Ho and Juliya Fisher and Andrew Mamalis and Edward Heilman and Nazanin Saedi and Jared Jagdeo",
year = "2017",
doi = "10.1097/DSS.0000000000001079",
language = "English (US)",
volume = "43",
pages = "635--648",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Striae distensae

T2 - Preventative and therapeutic modalities to improve aesthetic appearance

AU - Ross, Nicholas A.

AU - Ho, Derek

AU - Fisher, Juliya

AU - Mamalis, Andrew

AU - Heilman, Edward

AU - Saedi, Nazanin

AU - Jagdeo, Jared

PY - 2017

Y1 - 2017

N2 - BACKGROUND Striae distensae (SD) are aesthetically troublesome to patients and therapeutically challenging. OBJECTIVE Herein, the authors comprehensively review the literature pertaining to the history, pathogenesis, clinical presentation, clinical rating scales, and laboratory, imaging, and histologic features of SD. METHODS AND MATERIALS A review of PubMed, MEDLINE, Scopus, Embase, and Google scholar was conducted, including literature published from 1773 to August 6, 2016. RESULTS The authors identified 68 articles that met inclusion and exclusion criteria. CONCLUSION There are few randomized controlled trials evaluating the long-term efficacy and safety of various topical and energy-based devices. Based on clinical and anecdotal experience, both nonablative and ablative fractionated lasers have shown modest SD improvement compared with other treatment modalities (including Excimer laser, CuBr laser, pulsed dye laser, and 1,064-nm Nd:YAG laser). In the authors' experience, 1,540-nm nonablative fractionated laser is a worthy first-line modality for the treatment of SD. Future researchers may consider greater focus on enhanced study design, including larger, long-term split-body, or split-SD head-to-head randomized comparative trials with objective outcome measures and end points, such as biopsy and molecular studies demonstrating increased collagen and elastic fibers that correlate to clinical improvement.

AB - BACKGROUND Striae distensae (SD) are aesthetically troublesome to patients and therapeutically challenging. OBJECTIVE Herein, the authors comprehensively review the literature pertaining to the history, pathogenesis, clinical presentation, clinical rating scales, and laboratory, imaging, and histologic features of SD. METHODS AND MATERIALS A review of PubMed, MEDLINE, Scopus, Embase, and Google scholar was conducted, including literature published from 1773 to August 6, 2016. RESULTS The authors identified 68 articles that met inclusion and exclusion criteria. CONCLUSION There are few randomized controlled trials evaluating the long-term efficacy and safety of various topical and energy-based devices. Based on clinical and anecdotal experience, both nonablative and ablative fractionated lasers have shown modest SD improvement compared with other treatment modalities (including Excimer laser, CuBr laser, pulsed dye laser, and 1,064-nm Nd:YAG laser). In the authors' experience, 1,540-nm nonablative fractionated laser is a worthy first-line modality for the treatment of SD. Future researchers may consider greater focus on enhanced study design, including larger, long-term split-body, or split-SD head-to-head randomized comparative trials with objective outcome measures and end points, such as biopsy and molecular studies demonstrating increased collagen and elastic fibers that correlate to clinical improvement.

UR - http://www.scopus.com/inward/record.url?scp=85018438273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018438273&partnerID=8YFLogxK

U2 - 10.1097/DSS.0000000000001079

DO - 10.1097/DSS.0000000000001079

M3 - Review article

C2 - 28375972

AN - SCOPUS:85018438273

VL - 43

SP - 635

EP - 648

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 5

ER -